Oxygen Therapy Market By Product Type (Oxygen Cylinders, Oxygen Concentrators, Oxygen Masks, Oxygen Cannulas, Liquid Oxygen Systems), By Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Pneumonia, Cystic Fibrosis, Pulmonary Arterial Hypertension), By End-User (Hospitals, Home Healthcare, Long-Term Care Facilities, Ambulatory Surgical Centers, Clinics), By Delivery Mode (Continuous Flow Oxygen Therapy, Pulse Flow Oxygen Therapy), By Distribution Channel (Direct Sales, Online Sales, Retail Pharmacies, Medical Equipment Distributors), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Oxygen Therapy Market was valued at USD 35.0 Billion in 2024-e and will surpass USD 52.6 Billion by 2030; growing at a CAGR of 7.0% during 2025-2030.

The Oxygen Therapy market is a crucial segment of the global healthcare industry, driven by the increasing prevalence of chronic respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and sleep apnea. Oxygen therapy is used to deliver supplemental oxygen to patients with low blood oxygen levels, improving their overall quality of life. The market has witnessed significant growth due to advancements in technology, a rising geriatric population, and the growing demand for home healthcare solutions. Key segments include oxygen delivery systems, which encompass products like oxygen cylinders, concentrators, and masks. Additionally, the ongoing trend of home-based care is driving the demand for portable oxygen delivery devices.

Oxygen Cylinders Segment Is Largest Owing to Established Infrastructure and Widespread Use

Oxygen cylinders dominate the Oxygen Therapy market as the most widely used method for oxygen delivery. These cylinders are essential in hospitals, clinics, and home care settings, offering a reliable source of oxygen. Oxygen cylinders are favored due to their ease of use, portability, and immediate oxygen availability. Despite the growing popularity of oxygen concentrators, cylinders remain indispensable for emergency situations and short-term use, particularly in areas where access to electricity is unreliable. In hospitals and emergency care centers, oxygen cylinders are still the primary choice for ensuring a steady and uninterrupted supply of oxygen to critical patients. Their established infrastructure and availability in all healthcare settings contribute significantly to their market dominance.

Chronic Obstructive Pulmonary Disease (COPD) Segment Is Largest Owing to Rising Prevalence

Chronic Obstructive Pulmonary Disease (COPD) is the largest application segment for oxygen therapy, owing to its high prevalence and the long-term need for supplemental oxygen. COPD is a progressive lung disease that impairs airflow and causes shortness of breath, often requiring oxygen therapy to maintain adequate blood oxygen levels. The market for COPD-related oxygen therapy is expanding as the global burden of the disease increases, driven by factors such as smoking, environmental pollution, and an aging population. Moreover, the chronic nature of COPD means that patients often require long-term oxygen therapy, which fuels demand for both portable and stationary oxygen delivery devices. This segment is poised for continued growth as more COPD patients are diagnosed and treated with oxygen therapy.

Home Healthcare Segment Is Fastest Growing Owing to Shift Toward At-Home Care

Home healthcare is the fastest-growing end-user segment in the Oxygen Therapy market. This shift is largely driven by the growing preference for receiving medical care at home, especially for patients with chronic respiratory conditions who require long-term oxygen therapy. The rising cost of hospital stays and the increasing availability of portable oxygen concentrators have made home healthcare more accessible and affordable. Furthermore, advancements in remote patient monitoring and telehealth services are enhancing the effectiveness and convenience of home oxygen therapy. With the increasing focus on patient comfort and independence, home-based oxygen therapy solutions are gaining significant traction, especially in developed countries.

Pulse Flow Oxygen Therapy Segment Is Fastest Growing Owing to Efficiency and Portability

Pulse flow oxygen therapy is the fastest-growing delivery mode within the Oxygen Therapy market due to its efficiency and portability. Unlike continuous flow oxygen therapy, pulse flow systems deliver oxygen only when the patient inhales, making them more efficient and extending battery life for portable devices. This characteristic is particularly attractive for patients who require oxygen therapy while maintaining an active lifestyle. Pulse flow oxygen concentrators are smaller, lighter, and easier to carry compared to continuous flow devices, making them ideal for homecare and ambulatory applications. The increasing adoption of pulse flow oxygen therapy is expected to continue as patients seek more convenient and energy-efficient alternatives to traditional oxygen delivery methods.

Retail Pharmacies Segment Is Largest Distribution Channel Owing to Accessibility and Convenience

Retail pharmacies represent the largest distribution channel for oxygen therapy products, owing to their widespread accessibility and convenience for patients. Pharmacies often serve as the first point of contact for patients requiring oxygen therapy, offering a range of oxygen-related products such as cylinders, concentrators, and masks. The ability to obtain oxygen therapy products quickly from a local pharmacy plays a crucial role in patient care, especially for those in need of immediate relief or short-term therapy. Additionally, retail pharmacies provide valuable support in terms of product education, training, and home delivery services, further enhancing their role in the market.

North America Region Is Largest Owing to Advanced Healthcare Infrastructure and High Demand

North America dominates the Oxygen Therapy market due to its advanced healthcare infrastructure, high healthcare spending, and the growing prevalence of respiratory diseases such as COPD. The region is home to some of the largest healthcare providers and oxygen therapy companies, ensuring easy access to high-quality oxygen delivery products. Moreover, the increasing adoption of home healthcare solutions, along with the rising elderly population, is boosting demand for portable oxygen therapy devices. The U.S. and Canada, in particular, are witnessing a steady increase in the adoption of oxygen therapy products, driven by favorable reimbursement policies and a well-established healthcare system. North America's strong regulatory framework and established market players further contribute to its dominance in the global market.

Leading Companies and Competitive Landscape

The Oxygen Therapy market is highly competitive, with several key players contributing to the growth of the industry. Companies such as Philips Healthcare, Linde Group, Medtronic, Fisher & Paykel Healthcare, and ResMed are leading the market by offering innovative oxygen delivery solutions, expanding their product portfolios, and enhancing their global reach. These companies are focusing on strategic initiatives such as mergers and acquisitions, partnerships, and product innovations to strengthen their market position.

The competitive landscape is characterized by a mix of large multinational corporations and smaller, specialized players focusing on niche segments of the market. Companies are increasingly investing in research and development to introduce advanced oxygen therapy products that offer improved efficiency, portability, and patient comfort. Additionally, market players are expanding their presence in emerging markets to capitalize on the growing demand for oxygen therapy in regions with increasing respiratory disease burdens. The market is expected to witness further consolidation as companies seek to gain a competitive edge through innovation and strategic alliances.

List of Leading Companies:

• Philips Healthcare
• Invacare Corporation
• Linde Group
• Air Liquide
• Medtronic
• Fisher & Paykel Healthcare
• Becton Dickinson
• Drive DeVilbiss Healthcare
• Chart Industries
• Nidek Medical
• OxyCare Systems
• Omron Healthcare
• ResMed
• Kangji Medical
• Allied Healthcare Products Inc.

Recent Developments:

• Philips introduced a new lightweight and portable oxygen concentrator aimed at enhancing patient mobility and comfort during oxygen therapy.
• Air Liquide acquired a leading medical gas supplier to expand its oxygen therapy solutions in both home healthcare and hospital settings.
• Medtronic's new oxygen delivery system, designed for patients with severe respiratory conditions, received approval from the FDA for widespread use.
• Fisher & Paykel Healthcare announced the expansion of its oxygen therapy product line, including new CPAP and BiPAP machines, to enhance patient care for sleep apnea.
• ResMed launched an advanced home oxygen therapy system designed to simplify patient management and improve the overall experience for home care providers.

Report Scope: